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Abstract 
Objective: Objective of study was to investigate the frequency of erectile dysfunction in COPD patients. 
Methods: This cross sectional study was conducted in pulmonology department of Nishtar Hospital Multan. 336 
outpatients diagnosed as COPD according to Global Initiative of Chronic Lung Disease criteria, were included 
by non-probability consecutive sampling from February 2016 to august 2016 after taking the approval from 
ethics committee of the institution. Written consent of the study was signed by all patients. All patients were 
divided in mild, moderate, severe and very severe form of COPD on basis of FEV1. All patients completed 
International Index of Erectile Function (IIEF) Questionnaire. Data was analyzed by using SPSS vol 23. 
Numerical variables like age, BMI and duration of COPD were statistically analyzed by using their mean and 
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standard deviation and t-test was used to check their significance. Non numerical variables like area of living, 
income status, smoking status and different stages of COPD were statistically analyzed by using their frequency 
and chi square test was applied to check the significance. P value <0.05 was taken as significance. 
Results: Overall, 100% (n=336) male patients were included, in this study. The main outcome variable of this 
study was Erectile Dysfunction (ED). Classification of erectile dysfunction was noted as no, mild, moderate and 
severe as 32.7% (n=110), 23.5% (n=79), 16.4% (n=55) and 27.4% (n=92) respectively. Classification of chronic 
obstructive pulmonary disease (COPD) was observed as mild, moderate, severe and very severe as 5.1% (n=17), 
45.8% (n=154), 32.1% (n=108) and 17% (n=57) respectively. No association was found between erectile 
dysfunction and area (p=0.484), stratified age (p=0.970), stratified BMI (p=0.283), except income (p=0.000) and 
smoking status (p=0.000) 
Conclusion: Erectile dysfunction is hidden and under discuss comorbidity in COPD patients. There is significant 
prevalence of erectile dysfunction in COPD patients. All respiratory physicians should ask and investigate 
erectile dysfunction in COPD patients. All patients of COPD should be encouraged to share their sexual 
problems.  
Key words: COPD, Erectile dysfunction, sexual function 
 
Introduction 
  Chronic obstructive pulmonary disease(COPD) occurs mostly in individuals who are exposed to harmful gases, 
chemicals and particles {1}. COPD is the fifth most common cause of death {2} and it is expected to be the 3rd 
most common cause of death until 2020 {3}. Smoking is considered the major risk factor for the development of 
COPD {4}. All smokers do not develop COPD. But most of the cases of COPD (ABOUT 90% of them) have 
smoked.  COPD is characterized by persistent air flow limitation {5} and it is preventable and treatable disease. 
Patients with this disease show increased inflammatory response in lung bronchial tree {6}. This inflammation is 
not restricted to only lungs but has systemic effects. This is a disease of middle aged and older population. So 
many co morbidities are seen with COPD. Death in COPD patients are mostly due to cardiovascular events 
rather than respiratory failure {7}. 
    Erectile dysfunction is type of sexual dysfunction frequently found in mature and aging men. it is inability to 
reach or maintain sufficient erection to have satisfactory sexual activity {8}. Many factors result in erectile 
dysfunction like psychogenic and neural disorders, diabetes, hormonal imbalance, aging, vascular insufficiency, 
and due to side effects of many drugs. Erectile dysfunction negatively affects person’s self –esteem and also 
quality of life {9}. The mechanism of erectile dysfunction in COPD patients still not clear. Decrease functional 
capacity due to hypoxemia in COPD is thought to be the reason {10}. 
  Reports have shown that erectile dysfunction is common co morbidity in COPD patients. It is first reported by 
Fletcher and Martin in 1980s that 30 % COPD patients have erectile impotence. It is unfortunate that over the 
last 35 years the connection has been reported but this issue still appears to be largely unaddressed. 
   we have conducted this study to investigate frequency of erectile dysfunction in COPD patients. It will help to 
establish the facts about prevalence of this important co morbidity in our geographical area. In future this study 
will also provide the base for further investigation in this region of world. Study done by Onur Turan et al. in 
2015 {20} was taken as reference study. 
 
Materials and methodology 
  A cross sectional study was conducted in pulmonology department of Nishtar Hospital Multan. 336 outpatients 
diagnosed as COPD according to Global Initiative of Chronic Lung Disease criteria, were included by non-
probability consecutive sampling from February 2016 to august 2016 after taking approval of the study from 
ethics committee of the institution. Written consent of the study was signed by all patients. Patients diagnosed as 
other than COPD pulmonary disorders, low mental status, malignancy, COPD exacerbations in last three months 
and diabetes were excluded. Patients with abnormal hormonal levels were excluded. All patients with urogenital 
problems were also excluded. For our study sample size was calculated using reference from a previous study by 
Onur Turan et al. For which confidence interval was taken as 95 %, power of study 80, 67.7% of COPD patients 
have varying degree of erectile dysfunction. 
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 All COPD patients enrolled in study was taken from outpatient department. A detailed history of disease, 
duration of disease and history about any systemic disease was taken. Questions were asked about treatment 
history, history of drug and professional history. A detailed clinical examination was recorded. Personal data like 
age, smoking status, income and area of living were recorded by filling the Performa. The time of COPD 
diagnosis was taken from hospital record. Pulmonary status of patients was objectively assessed by pulmonary 
function test. Standard spirometry was done of all patients and best of the three values were recorded.  By this 
forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC) and FEV1/FVC were measured. The 
different stages of COPD were labelled as mild COPD (FEV1 >80%), moderate COPD (FEV1 50-80 %), sever 
COPD (FEV1 30-50%) and very sever COPD (FEV1 < 30%) according to GOLD criteria. 
  The patients completed International Index of Erectile Function (IIEF) Questionnaire. 
Erectile dysfunction and severity of erectile dysfunction were recorded with IIEF Questionnaire according to 
National Institute of Health criteria. Patients were asked about erection firmness, erection confidence, 
maintenance frequency, maintenance ability. Every parameter given five-point scale.  Low score represents poor 
sexual status and high score represent better sexual status. ED was divided into four categories as none (IIEF 
score 22-25), mild (17-22), moderate (12-16) and sever (5-11). Questions about sexual desire were evaluated 
separately. 
Hormone levels were also checked, which have influence on erectile dysfunction. Blood serum level of 
testosterone, free testosterone, luteinizing hormone, estradiol, prolactin, thyroid stimulating hormone and follicle 
stimulating hormone were recorded early in morning between 7 a.m. to 9 a.m. 
Data was analyzed by using SPSS vol 23. Numerical variables like age, BMI and duration of COPD were 
statistically analyzed by using their mean and standard deviation and t-test was used to check their significance. 
Non numerical variables like area of living, income status, smoking status and different stages of COPD were 
statistically analyzed by using their frequency and chi square test was applied to check the significance. P value 
<0.05 was taken as significance. 
 
Results 
Overall, 100% (n=336) male patients were included, in this study. There were 31.5% (n=106) patients lived in 
urban areas, while 68.5% (n=230) lived in rural areas. 47.9% (n=161) had low income, 34.8% (n=117) had 
moderate income and 17.3% (n=58) had good income. Smoking status showed that there were 64% (n=215) ex-
smokers, 14.9% (n=50) non-smokers and 21.1% (n=71) were smokers. The mean age and BMI of the patients 
was 60.21±3.98 years and 27.05±2.24 kg/m2 respectively. There were 12.8% (n=43) patients between 40-55 
years, while majority of the patients i.e. 87.2% (n=293) between 56-70 years of age. The distribution of BMI of 
the patients observed as; 23.2% (n=78) patients between 18-25 kg/m
2 
and 76.8% (n=258) patients between 26-32 
kg/m
2
. (Table. 1). 
The main outcome variable of this study was Erectile Dysfunction (ED).  Classification of ED was 
noted as no, mild, moderate and severe as 32.7% (n=110), 23.5% (n=79), 16.4% (n=55) and 27.4% (n=92) 
respectively (Table. 4). Classification of chronic obstructive pulmonary disease (COPD) was observed as mild, 
moderate, severe and very severe as 5.1% (n=17), 45.8% (n=154), 32.1% (n=108) and 17% (n=57) respectively. 
The mean smoking (pack years) and duration of COPD was 44.95±2.28 years and 61.99±1.93months 
respectively (Table. 2). ED status in COPD patients were shown in (Table. 3). 
No association was found between ED and area (p=0.484), stratified age (p=0.970), stratified BMI 
(p=0.283), except income (p=0.000) and smoking status (p=0.000). So, income and smoking status were the 
effect modifiers for ED. There was no statistical significant difference between means of smoking pack years 
(p=0.319) and duration of COPD (p=0.238). (Table. 1-2). 
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Table. 1 
Demographic Variables 
 
 
Characteristics Frequency Percentage (%) Test of Sig. 
Area 
Rural 230 68.5 χ2 =2.45 
p=0.484 Urban 106 31.5 
Total 336 100.0 
Income 
Low 161 47.9 χ2 =39.66 
p=0.000 Moderate 117 34.8 
Good 58 17.3 
Total 336 100.0 
Smoking Status 
Smoker 71 21.1 χ
2 
=37.28 
p=0.000 Non-Smoker 50 14.9 
Ex-Smoker 215 64.0 
Total 336 100.0 
Stratified Age 
40-55 Years 43 12.8 χ
2 
=0.243 
p=0.970 56-70 Years 293 87.2 
Total 336 100.0 
Stratified BMI 
18-25  kg/m
2
 78 23.2 χ
2 
=3.806 
p=0.283 26-32 kg/m
2
 258 76.8 
Total 336 100.0 
Descriptive Statistics (Mean±S.D) 
Age 60.21±3.98 years 
BMI 27.05±2.24 kg/m
2
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Table. 2 
Characteristics of COPD 
 
 
 
 
  
 
 
 
           
COPD: chronic obstructive pulmonary disease. 
 
Table. 3 
ED status in COPD patients 
Classification of 
COPD 
Classification of ED 
No Mild Moderate Severe Total 
Mild 10 3 2 2 17 
Moderate 94 57 1 2 154 
Severe 3 16 50 39 108 
Very Severe 3 3 2 49 57 
Total 110 79 55 92 336 
COPD: chronic obstructive pulmonary disease; ED: erectile dysfunction. 
 
Table. 4 
Classification of ED 
 
 
 
 
 
 
 
Discussion 
Sexuality has significant effect on quality of life of human beings {11}. It is natural instinct and source of 
amusement. Sexual dysfunction disturbed human life in many ways. Erectile dysfunction is type of sexual 
dysfunction. It is common disorder of elderly men over age of 50 years and it is studied that about one third of 
Stages Frequency Percentage (%) Test of Sig. 
Mild 17 5.1 χ
2 
=31.02 
p=0.000 Moderate 154 45.8 
Severe 108 32.1 
Very Severe 57 17.0 
Total 336 100. 
Descriptive Statistics (Mean±S.D) 
Smoking (pack years) 44.95±2.28 years t=0.998 
p=0.319 
Duration of COPD 61.99±1.93 months t=-0.184 
p=0.238 
Classification Frequency Percentage (%) 
No 110 32.7 
Mild 79 23.5 
Moderate 55 16.4 
Severe 92 27.4 
Total  336 100.0 
ED: erectile dysfunction. 
Journal of Medicine, Physiology and Biophysics                                                                                                                              www.iiste.org 
ISSN 2422-8427     An International Peer-reviewed Journal 
Vol.43, 2018 
 
18 
male population over the age of 50 is effected by sexual dysfunction {12}. Cause of erectile dysfunction is multi 
factorial {13}. It is caused by physical, mental and psychological problems. 
Many studies have investigated the association of COPD with erectile dysfunction. Patients with COPD are at 
higher risk of developing erectile dysfunction compared to general population. A cohort study done in Taiwan 
showed that the cumulative incidence of erectile dysfunction in the COPD cohort was approximately 1.29% 
higher than that in the non-COPD cohort {18}. Poor control of COPD and more will be the erectile dysfunction. 
In one study erectile dysfunction was present 83.3% in COPD patients {19}. In our study the overall prevalence 
of erectile dysfunction was found 67.2% which is very close to other study {20}. So these studies show that 
erectile dysfunction is a common problem in COPD patients. It affects human life in many ways.  
 Erectile dysfunction is common comorbidity in many diseases {14}. Patients with diabetes, COPD, 
cardiovascular diseases, chronic renal failure, malignancy suffer this comorbidity. Smoking and decrease 
functional capacity are independent factors that affect negatively on human sexual life. Prevalence of sexual 
dysfunction in these systemic diseases is higher than general population. Diabetic men show threefold 
probability of having erectile dysfunction than men without diabetes {15}.  
In cardiovascular diseases erectile dysfunction is considered another manifestation of same systemic disorder 
and it often precedes cardio vascular disease onset and might be considered early marker of cardio vascular 
disease {16}. All elderly patients with vasculogenic erectile dysfunction should be screened for cardio vascular 
disease {17}. Similarly, patients with chronic renal failure and malignancy show increased probability of 
developing erectile dysfunction. 
Unluckily in clinical practice of respiratory medicine clinicians focus more on bronchospasm, dyspnea, 
infections and respiratory failure and they fail to ask and investigate erectile dysfunction in COPD patients {21}. 
A study also show that COPD patients also hesitate to share about sexual dysfunction {12}.  
 Association of COPD and ED is not a straightforward matter. The presence of co-morbidities and risk factors 
like smoking, decrease functional capacity and aging make is difficult to distinguish what came first the ED or 
COPD. 
 The exact mechanism of erectile dysfunction in COPD is unclear. Hypoxemia is main factor in developing 
erectile dysfunction {22}. It results in reduce activity of nitric oxide synthase which cause vasoconstriction. 
Erection is hemodynamic event and it is caused by dilatation of penile arteries and relaxation of smooth muscles 
in corpus cavernosum. This all is mediated by nitric oxide which in turn is effected by hypoxemia.  
 COPD is disease of smokers. Smoking is established risk factor and is strongly associated with erectile 
dysfunction. Increased oxidative stress and endothelial dysfunction are major mechanism that result in erectile 
dysfunction {23}. The result of one study showed that risk of developing erectile dysfunction in current smokers 
was increased by 51% and 20% in ex-smokers as compared to nonsmokers {24}. 
Our study like other studies showed a significant prevalence erectile dysfunction in COPD patients. So it is very 
important for physicians to inquire about sexual dysfunction in COPD patients. 
Limitation of the study was that sample size used in this research was relatively small and other factors of 
erectile dysfunction in these patients were not analyzed and compared. 
 
Conclusion 
Results of our study showed that erectile dysfunction in significantly prevalent in COPD patients. Erectile 
dysfunction is hidden comorbidity in COPD patients. Respiratory physicians should ask and investigate about 
sexual dysfunction in these patients. Patients should also be encouraged to talk about and share the sexual 
problem.  
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